Author Title [ Type(Asc)] Year
Filters: Author is Xhaard, Aliénor  [Clear All Filters]
Journal Article
Ruggiu M, Bedossa P, Rautou PEmmanuel, Bertheau P, Plessier A, de Latour RPeffault, Robin M, de Fontbrune FSicre, Pagliuca S, Villate A, et al. Utility and safety of liver biopsy in patients with undetermined liver blood test anomalies after allogeneic hematopoietic stem cell transplantation, a monocentric retrospective cohort study. Biol Blood Marrow Transplant. 2018.
de Fontbrune FSicre, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay J-O, Neven B, Moussi J, Simon L, et al. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC. Transplantation. 2015.
Piñana JLuis, Xhaard A, Tridello G, Passweg J, Kozijn A, Polverelli N, Heras I, Pérez A, Sanz J, Berghuis D, et al. Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation. J Infect Dis. 2020.
Dong S, Maiella S, Xhaard A, Pang Y, Wenandy L, Larghero J, Becavin C, Benecke A, Bianchi E, Socié G, et al. Multi-parameter single-cell profiling of human CD4+FOXP3+ regulatory T cell populations in homeostatic conditions and during graft-versus-host disease. Blood. 2013.
Meunier M, Manez A-C, Xhaard A, de Latour RPeffault, de Fontbrune FSicre, Dhedin N, Socié G, Robin M. Late Donor Bone Marrow Failure After Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation. 2014;97(12):e75-e77.
Cesaro S, Tridello G, Knelange NSimone, Blijlevens N, Martin M, Snowden JA, Malladi R, Ljungman P, Deconinck E, Gedde-Dahl T, et al. Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT. Bone Marrow Transplant. 2021.
Giannoni L, Morin F, Robin M, Peyneau M, Schlageter MHélène, Desmier D, Pagliuca S, Del Galy ASutra, de Fontbrune FSicre, Xhaard A, et al. Human-derived α1-antitrypsin is still efficacious in heavily pretreated patients with steroid-resistant gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2020.
Loschi M, Porcher R, de Latour RPeffault, Vanneaux V, Robin M, Xhaard A, de Fontebrune FSicre, Larghero J, Socié G. High Number of memory T cells is associated with higher risk Of acute GVHD after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2014.
O'Meara A, Boukouaci W, Robin M, Xhaard A, Fortier C, Marzais F, de Fontbrune FSicre, de Latour RPeffault, Charron D, Socié G, et al. GLCCI1 and GR genetic diversity and response to glucocorticoid-based treatment of graft-versus-host disease. Biol Blood Marrow Transplant. 2015.
Itzykson R, Robin M, Moins-Teisserenc H, Delord M, Busson M, Xhaard A, de Fontbrune FSicre, de Latour RPeffault, Toubert A, Socié G. Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation. Haematologica. 2014.
von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, Giordani MTeresa, Schnitzler P, Bettinger D, Thimme R, et al. The Burden of Hepatitis E among Patients with Hematological Malignancies: a Retrospective European Cohort Study. J Hepatol. 2019.
Xhaard A, Villate A, Hamane S, Michonneau D, Menotti J, Robin M, de Fontbrune FSicre, Dhedin N, de la Tour RPeffault, Socié G, et al. A 10-year retrospective analysis of Toxoplasma gondii qPCR screening in allogeneic hematopoietic stem cell transplantation recipients. Bone Marrow Transplant. 2022.